$19.57+44% 1Y

Price

+44%1Y

End-of-day closes, not the intraday tick.

More going right than wrong

Quality mixed, no red flags, price roughly fair, growing in the filings, the market undecided.

RyuScore 53 of 100: see how it is built
What they do

At Kenvue, our purpose is to realize the extraordinary power of everyday care. As a global leader at the intersection of healthcare and consumer goods, we are the world’s largest pure-play consumer health company by revenue with $15.1 billion in Net sales in the fiscal year 2025. By combining the power of science with meaningful consumer insights and our digital strategy, we empower consumers to live healthier lives every day.

In the company’s own words · 10-K filed Feb 20, 2026 · SEC EDGAR

P/E22.5
Market value$37.59B
1 year+44%
5 yearsn/a

Charts

As reported to the SEC, without any scoring.

Kenvue (KVUE) reported revenue of $3.96B in Q2 2026 (quarter ended Jun 28, 2026), up 3.0% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $456M (12% of revenue). For the full year FY2025, revenue was $15.1B (−2.1% year on year) and net income $1.47B. Its largest segment in Q2 2026 was Self Care at $1.59B, 40% of the disclosed total, ahead of Essential Health at 32%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

  1. Oct 13, 2026On October 9, 2026, Kenvue Inc. (the “Company”) entered into a Third Supplemental Indenture dated as of October 9, 2026 (the “Third Supplemental Indenture”), to the indenture dated as of March 22, 2023, between the Company and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”) (the “Base Indenture”), as …Material agreement entered · Form 8-K
  2. Apr 15, 2026On February 12, 2026, Kenvue Inc. (the “Company”) announced that Amit Banati, the current Chief Financial Officer, will step down from his role effective May 12, 2026.Director or officer change · Form 8-K
  3. Feb 17, 2026On February 17, 2026, the Company’s Board of Directors approved an initiative that aims to optimize its operating model, transform its supply chain, reduce complexity, and drive operational efficiencies, while strengthening core capabilities.Earnings release · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.

Business segments

Q2 2026 · $3.96B

The company’s own SEC segment disclosure.

  • Self Care$1.59B40%
  • Essential Health$1.25B32%
  • Skin Health And Beauty$1.11B28%

Why these answers

Each answer with the checks it was read from. Open one for the numbers.

17/19 checks · as of Oct 23, 2026

Conflicts between checks are named, never averaged, and thin data says so.